214 related articles for article (PubMed ID: 18293166)
1. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
[TBL] [Abstract][Full Text] [Related]
2. Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor Beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro.
Sheng L; Yang X; Ye P; Liu YX; Han CG
Chin Med Sci J; 2015 Dec; 30(4):245-51. PubMed ID: 26960306
[TBL] [Abstract][Full Text] [Related]
3. [Atorvastatin upregulates the expression of PPAR alpha/gamma and inhibits the hypertrophy of cardiac myocytes in vitro].
Sheng L; Ye P; Liu YX
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1080-4. PubMed ID: 16563274
[TBL] [Abstract][Full Text] [Related]
4. Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases.
Barlaka E; Görbe A; Gáspár R; Pálóczi J; Ferdinandy P; Lazou A
Pharmacol Res; 2015; 95-96():102-10. PubMed ID: 25828396
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
[TBL] [Abstract][Full Text] [Related]
6. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
Ye P; Yang W; Wu SM; Sheng L
Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Pflugers Arch; 2007 Dec; 455(3):443-54. PubMed ID: 17643263
[TBL] [Abstract][Full Text] [Related]
8. GW0742 reduces mast cells degranulation and attenuates neurological impairments via PPAR
Lu W; Huang J; Flores J; Li P; Wang W; Liu S; Zhang JH; Tang J
Exp Neurol; 2024 Feb; 372():114615. PubMed ID: 37995951
[TBL] [Abstract][Full Text] [Related]
9. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
[TBL] [Abstract][Full Text] [Related]
10. PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts.
Zhang H; Pi R; Li R; Wang P; Tang F; Zhou S; Gao J; Jiang J; Chen S; Liu P
Arch Biochem Biophys; 2007 Apr; 460(1):25-32. PubMed ID: 17346664
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats.
Collino M; Benetti E; Miglio G; Castiglia S; Rosa AC; Aragno M; Thiemermann C; Fantozzi R
Free Radic Biol Med; 2011 Jan; 50(2):345-53. PubMed ID: 21047550
[TBL] [Abstract][Full Text] [Related]
12. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor beta stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin.
Wagner N; Jehl-Piétri C; Lopez P; Murdaca J; Giordano C; Schwartz C; Gounon P; Hatem SN; Grimaldi P; Wagner KD
Cardiovasc Res; 2009 Jul; 83(1):61-71. PubMed ID: 19351742
[TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.
Quintela AM; Jiménez R; Gómez-Guzmán M; Zarzuelo MJ; Galindo P; Sánchez M; Vargas F; Cogolludo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
Free Radic Biol Med; 2012 Aug; 53(4):730-41. PubMed ID: 22683600
[TBL] [Abstract][Full Text] [Related]
15. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
16. Effect of PPAR-β/δ agonist GW0742 treatment in the acute phase response and blood-brain barrier permeability following brain injury.
Chehaibi K; le Maire L; Bradoni S; Escola JC; Blanco-Vaca F; Slimane MN
Transl Res; 2017 Apr; 182():27-48. PubMed ID: 27818230
[TBL] [Abstract][Full Text] [Related]
17. Effects of peroxisome proliferator-activated receptor-β/δ on sepsis induced acute lung injury.
Wang C; Zhou G; Zeng Z
Chin Med J (Engl); 2014; 127(11):2129-37. PubMed ID: 24890166
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
19. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
[TBL] [Abstract][Full Text] [Related]
20. Activation of PPARβ/δ prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteries.
Morales-Cano D; Moreno L; Barreira B; Briones AM; Pandolfi R; Moral-Sanz J; Callejo M; Mondejar-Parreño G; Cortijo J; Salaices M; Duarte J; Perez-Vizcaino F; Cogolludo A
Clin Sci (Lond); 2016 Oct; 130(20):1823-36. PubMed ID: 27413020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
